Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yeti Biomedical is a Massachusetts-based independent medical device consulting firm focused on cardiovascular implants, biomaterials, and minimally invasive cardiovascular procedures. The company provides design, development, and commercialization support for medical device programs, including concept due diligence, intellectual property strategy, market research, preclinical testing, and regulatory support. Its expertise is concentrated in structural heart and transcatheter cardiovascular technologies rather than a traditional therapeutic drug pipeline. Founder Carol Devellian has decades of experience developing implantable cardiovascular devices and has worked across product development, manufacturing, and commercialization. Yeti Biomedical appears to operate as a specialized advisory and development services company for medtech innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YETI.